BARDA is the gift that keeps on giving!
The health economics and outcomes project that they have commissioned IQVIA to do on BTM use is an unexpected bonus from the collaboration.
Not only will we get an announcement to market next week on the results of the clinical trial but soon after, in September, the first of three reports done by IQVIA.
So much to look forward to this FY.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.035(2.64%) |
Mkt cap ! $891.1M | |||
| Open | High | Low | Value | Volume |
| $1.33 | $1.35 | $1.29 | $2.596M | 1.984M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 66524 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 11567 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PNV (ASX) Chart |